{"id":87509,"date":"2019-02-06T16:02:22","date_gmt":"2019-02-07T00:02:22","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/02\/potential-alzheimers-therapy-ub-311-safe-effective-phase-2a-trial-finds"},"modified":"2019-02-06T16:02:22","modified_gmt":"2019-02-07T00:02:22","slug":"potential-alzheimers-therapy-ub-311-safe-effective-phase-2a-trial-finds","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/02\/potential-alzheimers-therapy-ub-311-safe-effective-phase-2a-trial-finds","title":{"rendered":"Potential Alzheimer\u2019s Therapy UB-311 Safe, Effective, Phase 2a Trial Finds"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/potential-alzheimers-therapy-ub-311-safe-effective-phase-2a-trial-finds3.jpg\"><\/a><\/p>\n<p>United Neuroscience\u2019s Alzheimer\u2019s vaccine candidate UB-311 was found safe and well-tolerated, triggering an antibody response against beta-amyloid in most of the patients, according to Phase 2a trial results.<\/p>\n<p><a href=\"https:\/\/alzheimersnewstoday.com\/\">https:\/\/alzheimersnewstoday.com\/<\/a>\u2026\/ub-311-safe-effective-ph\u2026\/<\/p>\n<p><!-- Link: <a href=\"https:\/\/alzheimersnewstoday.com\/2019\/01\/25\/ub-311-safe-effective-phase-2a-trial\/?amp\">https:\/\/alzheimersnewstoday.com\/2019\/01\/25\/ub-311-safe-effec...trial\/?amp<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>United Neuroscience\u2019s Alzheimer\u2019s vaccine candidate UB-311 was found safe and well-tolerated, triggering an antibody response against beta-amyloid in most of the patients, according to Phase 2a trial results. https:\/\/alzheimersnewstoday.com\/\u2026\/ub-311-safe-effective-ph\u2026\/<\/p>\n","protected":false},"author":507,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-87509","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/87509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/507"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=87509"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/87509\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=87509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=87509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=87509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}